Douglas VanNostrand

  • Dr. VanNostrand is the Dir NucMed Research, MedStar Research Inst and Wash HospCtr.  He received his BS from Duke(1969), MD from Emory Univ(1973), residency Int Med Wilford Hall MedCtr(1976), fellowship Nucl Med Naval MedCtr(1978).  He was previously the Dir Nucl Med Malcolm Grow MedCtr(1979-1980), Walter Reed Army MedCtr(1980-1987), Good Samaritan Hosp(1987-1999) and MedStar Wash HosptCr(1999-2015).   He became DirNuclMed Research Institute in Jan2016, is Prof of Med Georgetown Univ Sch Med, has won numerous awards, has been actively involved in thyroid cancer diagnosis/treatment for over ~40 years.  He has published more than 200 articles/9 books including the 3rd edition of the medical textbook entitled, Thyroid Cancer:  A Comprehensive Guide to Clinical Management edited by Wartofsky, VanNostrand, and Thyroid Cancer: A Guide for Patients edited by VanNostrand, Wartofsky, Bloom, Kulkarni, which has been translated into Spanish and Chinese.  His major area of research is thyroid cancer and nuclear medicine.


     

 

Leave a Reply

  • Upcoming Events

     

    World Congress on Thyroid Cancer 3.5
    Rome, Italy | 2019

    Steering Committee
    Rocco Bellatone, MD, Co-Chair
    Celestino Lombardi, MD, Co-Chair
    Gregory Randolph, MD
    Bryan McIver, MD
    Jeremy Freeman, MD
    Ian J. Witterick, MD
    Ashok R. Shaha, MD
    Jatin P. Shah, MD

    World Congress on Thyroid Cancer 4.0
    July 29 – August 1, 2021
    Boston, Massachusetts

     

  • WCTC3.5 Steering Committee:

     

    Rocco Bellatone, Co-Chair
    Celestino Lombardi, Co-Chair
    Gregory W. Randolph, MD
    Bryan McIver, MD
    Jeremy Freeman, MD
    Ian J. Witterick, MD
    Ashok R. Shaha, MD
    Jatin P. Shah, MD